Financial hardship after hematopoietic cell transplantation

Lack of impact on survival

Nandita D Khera, Randy Albelda, Theresa Hahn, Diana Salas Coronado, Oreofe O. Odejide, Robert J. Soiffer, Gregory A. Abel

Research output: Contribution to journalArticle

Abstract

Background: Financial hardship is a growing challenge for patients with blood cancer who undergo hematopoietic cell transplantation (HCT), and it is associated with poor patient-reported outcomes. In contrast, little is known about the potential impact of patient-reported financial hardship on post-HCT survival. Methods: We sought to describe the association of financial hardship with survival after HCT in a prospectively assembled cohort of patients from three large transplant centers (n = 325). Results: There was no association between financial hardship measures assessed at 6 months post-HCT and 1- or 2-year survival after HCT. Conclusions: Patient-reported financial distress after HCTdoes not seem to adversely affect post-HCT survival. Impact: When assessing the effectiveness of interventions to ameliorate familial financial burden among HCT, the focus should be on patient-reported outcomes rather than survival.

Original languageEnglish (US)
Pages (from-to)345-347
Number of pages3
JournalCancer Epidemiology Biomarkers and Prevention
Volume27
Issue number3
DOIs
StatePublished - Mar 1 2018

Fingerprint

Cell Transplantation
Survival
Cell Survival
Transplants
Neoplasms

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Financial hardship after hematopoietic cell transplantation : Lack of impact on survival. / Khera, Nandita D; Albelda, Randy; Hahn, Theresa; Coronado, Diana Salas; Odejide, Oreofe O.; Soiffer, Robert J.; Abel, Gregory A.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 27, No. 3, 01.03.2018, p. 345-347.

Research output: Contribution to journalArticle

Khera, Nandita D ; Albelda, Randy ; Hahn, Theresa ; Coronado, Diana Salas ; Odejide, Oreofe O. ; Soiffer, Robert J. ; Abel, Gregory A. / Financial hardship after hematopoietic cell transplantation : Lack of impact on survival. In: Cancer Epidemiology Biomarkers and Prevention. 2018 ; Vol. 27, No. 3. pp. 345-347.
@article{4ff6b82074d948908c20c3278b9a7160,
title = "Financial hardship after hematopoietic cell transplantation: Lack of impact on survival",
abstract = "Background: Financial hardship is a growing challenge for patients with blood cancer who undergo hematopoietic cell transplantation (HCT), and it is associated with poor patient-reported outcomes. In contrast, little is known about the potential impact of patient-reported financial hardship on post-HCT survival. Methods: We sought to describe the association of financial hardship with survival after HCT in a prospectively assembled cohort of patients from three large transplant centers (n = 325). Results: There was no association between financial hardship measures assessed at 6 months post-HCT and 1- or 2-year survival after HCT. Conclusions: Patient-reported financial distress after HCTdoes not seem to adversely affect post-HCT survival. Impact: When assessing the effectiveness of interventions to ameliorate familial financial burden among HCT, the focus should be on patient-reported outcomes rather than survival.",
author = "Khera, {Nandita D} and Randy Albelda and Theresa Hahn and Coronado, {Diana Salas} and Odejide, {Oreofe O.} and Soiffer, {Robert J.} and Abel, {Gregory A.}",
year = "2018",
month = "3",
day = "1",
doi = "10.1158/1055-9965.EPI-17-1040",
language = "English (US)",
volume = "27",
pages = "345--347",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - Financial hardship after hematopoietic cell transplantation

T2 - Lack of impact on survival

AU - Khera, Nandita D

AU - Albelda, Randy

AU - Hahn, Theresa

AU - Coronado, Diana Salas

AU - Odejide, Oreofe O.

AU - Soiffer, Robert J.

AU - Abel, Gregory A.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Background: Financial hardship is a growing challenge for patients with blood cancer who undergo hematopoietic cell transplantation (HCT), and it is associated with poor patient-reported outcomes. In contrast, little is known about the potential impact of patient-reported financial hardship on post-HCT survival. Methods: We sought to describe the association of financial hardship with survival after HCT in a prospectively assembled cohort of patients from three large transplant centers (n = 325). Results: There was no association between financial hardship measures assessed at 6 months post-HCT and 1- or 2-year survival after HCT. Conclusions: Patient-reported financial distress after HCTdoes not seem to adversely affect post-HCT survival. Impact: When assessing the effectiveness of interventions to ameliorate familial financial burden among HCT, the focus should be on patient-reported outcomes rather than survival.

AB - Background: Financial hardship is a growing challenge for patients with blood cancer who undergo hematopoietic cell transplantation (HCT), and it is associated with poor patient-reported outcomes. In contrast, little is known about the potential impact of patient-reported financial hardship on post-HCT survival. Methods: We sought to describe the association of financial hardship with survival after HCT in a prospectively assembled cohort of patients from three large transplant centers (n = 325). Results: There was no association between financial hardship measures assessed at 6 months post-HCT and 1- or 2-year survival after HCT. Conclusions: Patient-reported financial distress after HCTdoes not seem to adversely affect post-HCT survival. Impact: When assessing the effectiveness of interventions to ameliorate familial financial burden among HCT, the focus should be on patient-reported outcomes rather than survival.

UR - http://www.scopus.com/inward/record.url?scp=85045505164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045505164&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-17-1040

DO - 10.1158/1055-9965.EPI-17-1040

M3 - Article

VL - 27

SP - 345

EP - 347

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 3

ER -